Anti-fibrotic efficacy of nintedanib in pulmonary fibrosis via the inhibition of fibrocyte activity
Respiratory Research Oct 01, 2017
Sato S, et al. - This study investigated the impacts of nintedanib on the functions of fibrocytes. Findings supported the role of fibrocytes as producers of and responders to growth factors. Data also indicated that nintedanib's anti-fibrotic impacts were at least partly mediated by suppression of fibrocyte function.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries